Kamada Ltd Stock Prediction
AI-powered sentiment analysis and prediction trends for KMDA, updated each market day.
KMDA AI Sentiment
AI sees no strong directional signal for Kamada Ltd stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Kamada Ltd
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Exchange
Market Cap
$461,105,336
Cap Tier
Employees
462
Listed Since
May 31, 2013
Website
KMDA Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KMDA Volatility
Kamada Ltd has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
